白介素-6水平升高预测儿童肺动脉高压临床恶化
该研究在儿童肺动脉高压(PAH)两个队列中评估血清白介素-6(IL-6)与疾病严重程度及临床恶化的关联。
要点
- IL-6每升高一个对数单位与更差的血流动力学指标显著相关。
- IL-6或可作为儿童PAH无创监测与预后评估的潜在指标。
核心结论
- IL-6与儿童PAH基线及随访期间更差的血流动力学显著相关,并可能与临床恶化相关。
研究设计与样本
- 横断面队列来自NHLBI PAH生物样本库(n=175),纵向队列来自Children's Hospital Colorado(CHC)(n=61),采用ELISA法检测血清IL-6。
- 使用回归分析和Kaplan-Meier分析评估IL-6与疾病严重程度及结局的关联。
主要发现
- 在PAH生物样本库队列中,校正年龄和性别后,IL-6每增加一个对数单位与更高的肺血管阻力指数显著相关。
- 在PAH生物样本库队列中,IL-6每增加一个对数单位与特发性PAH或前列腺素治疗的概率降低显著相关,与修复性先天性分流相关PAH的概率升高显著相关。
- 在CHC队列中,IL-6每增加一个对数单位与随访期间更高的平均肺动脉压显著相关。
临床怎么用
- IL-6可能为儿童PAH提供一种较无创的疾病监测和预后评估方法。
- IL-6可作为儿童PAH的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether circulating interleukin-6 (IL-6) is associated with measures of disease severity and clinical worsening in pediatric pulmonary arterial hypertension (PAH). STUDY DESIGN: IL-6 was measured by enzyme-linked immunosorbent assay in serum samples from a cross-sectional cohort from the National Heart, Lung, and Blood Institute Pulmonary Arterial Hypertension Biobank (n = 175) and a longitudinal cohort from Children's Hospital Colorado (CHC) (n = 61). Associations between IL-6, disease severity, and outcomes were studied with regression and Kaplan-Meier analysis. RESULTS: In analyses adjusted for age and sex, each log-unit greater IL-6 was significantly associated in the Pulmonary Arterial Hypertension Biobank cohort with greater pulmonary vascular resistance indices, lower odds of having idiopathic PAH or treatment with prostacyclin, and greater odds of having PAH associated with a repaired congenital shunt. In the CHC cohort, each log-unit greater IL-6 was significantly associated with greater mean pulmonary arterial pressure over time. Kaplan-Meier analysis in the CHC cohort revealed that IL-6 was significantly associated with clinical worsening (a composite score of mortality, transplant, or palliative surgery) (P = .037). CONCLUSIONS: IL-6 was significantly associated with worse hemodynamics at baseline and over time and may be associated with clinical worsening. IL-6 may provide a less-invasive method for disease monitoring and prognosis in pediatric PAH as well as a potential therapeutic target.
引用
- Chen JY, Griffiths M, Yang J, et al. Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension. J Pediatr. 2020. PMID: 32711743. doi:10.1016/j.jpeds.2020.04.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。